Tarragona, Spain

Anna Trojanowska

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Procter & Gamble International Operations Sa. Active years: 2021.


% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Anna Trojanowska

Introduction

Anna Trojanowska is a notable inventor based in Tarragona, Spain. She has made significant strides in the field of microencapsulation technology, particularly with her innovative work on photosensitive microcapsules. Her contributions have the potential to impact various industries, including cosmetics and pharmaceuticals.

Latest Patents

Anna holds a patent for her invention titled "Photosensitive Microcapsules." This invention features a photosensitive microcapsule that has a shell encapsulating a core material. The core material can comprise a benefit agent, while the shell is made of a photosensitive polymer. The polymer includes one or more photosensitive moieties that contain a substituted amine and a 1,3 dione moiety. Notably, the core material can be released from the microcapsule upon exposure to an electromagnetic radiation field, which can include infrared radiation, visible light, ultraviolet radiation, and mixtures thereof. This innovative approach opens new avenues for targeted delivery systems.

Career Highlights

Anna Trojanowska is currently employed at Procter & Gamble International Operations S.A. Her role at this leading company allows her to collaborate with other talented professionals in the field.

Collaborations

Some of her notable coworkers include Bartosz Tylkowski and Luke Andrew Zannoni. Their collective expertise contributes to the advancement of innovative solutions within the company.

Conclusion

Anna Trojanowska's work exemplifies the spirit of innovation and creativity in the field of microencapsulation. Her patented technology has the potential to revolutionize how benefit agents are delivered in various applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…